Innovative Technology Prescient Surgical's flagship product, CleanCision™, offers an advanced active cleansing system specifically designed to reduce surgical site infections, presenting a unique value proposition for hospitals seeking to improve patient outcomes and meet infection control standards.

Recent Industry Recognition The company has received industry accolades, including finalist status at the 2018 Medical Design Excellence Awards, which can be leveraged to build credibility and attract new hospital clients looking for proven, award-winning solutions.

Strategic Partnerships With recent contractual agreements such as the group purchasing agreement with Premier, there are emerging opportunities to expand sales through hospital networks and procurement collaborations aligned with innovative infection prevention technologies.

Funding and Growth Potential Having secured $10M in Series B funding from strategic investors like Baxter Ventures indicates strong backing and growth prospects, creating opportunities for strategic partnerships, joint ventures, and increased outreach to hospitals focused on cutting-edge surgical safety solutions.

Market Expansion Readiness Prescient Surgical’s focus on technology innovation and ongoing collaborations with hospitals position it well for growth in the competitive medical device field, especially as the healthcare industry increasingly prioritizes infection prevention and patient safety improvements.